Mannan S. Nouri

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancer.

Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancer.

Journal: Cell reports

Published: April 04, 2024

Increased chromatin accessibility mediated by nuclear factor I drives transition to androgen receptor splice variant dependence in castration-resistant prostate cancer.

Increased chromatin accessibility mediated by nuclear factor I drives transition to androgen receptor splice variant dependence in castration-resistant prostate cancer.

Journal: bioRxiv : the preprint server for biology

Published: January 23, 2024

AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer.

AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer.

Journal: Molecular cancer therapeutics

Published: December 29, 2023

BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stress.

BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stress.

Journal: Nature communications

Published: October 20, 2023

A carboxy-terminal ubiquitylation site regulates androgen receptor activity.

A carboxy-terminal ubiquitylation site regulates androgen receptor activity.

Journal: Communications biology

Published: April 03, 2023

Telehealth experiences in Canadian veterans: associations, strengths and barriers to care during the COVID-19 pandemic.

Telehealth experiences in Canadian veterans: associations, strengths and barriers to care during the COVID-19 pandemic.

Journal: BMJ military health

Published: November 02, 2022

Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling.

Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling.

Journal: Cancer research

Published: May 09, 2022

Androgen receptor splice variant 7 functions independently of the full length receptor in prostate cancer cells.

Androgen receptor splice variant 7 functions independently of the full length receptor in prostate cancer cells.

Journal: Cancer letters

Published: April 20, 2021

Androgen receptor and MYC equilibration centralizes on developmental super-enhancer.

Androgen receptor and MYC equilibration centralizes on developmental super-enhancer.

Journal: Nature communications

Published: April 13, 2021

Gli activation by the estrogen receptor in breast cancer cells: Regulation of cancer cell growth by Gli3.

Gli activation by the estrogen receptor in breast cancer cells: Regulation of cancer cell growth by Gli3.

Journal: Molecular and cellular endocrinology

Published: March 23, 2020

MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation.

MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation.

Journal: eLife

Published: January 07, 2020

The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer.

The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer.

Journal: Nature communications

Published: November 05, 2019

Showing 1-12 of 22

Last Updated: 09/26/2026